A detailed history of Riverview Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Riverview Trust CO holds 110 shares of REGN stock, worth $83,249. This represents 0.1% of its overall portfolio holdings.

Number of Shares
110
Previous 108 1.85%
Holding current value
$83,249
Previous $113,000 1.77%
% of portfolio
0.1%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$1024.09 - $1201.76 $2,048 - $2,403
2 Added 1.85%
110 $115,000
Q2 2024

Jul 16, 2024

BUY
$883.2 - $1071.19 $30,028 - $36,420
34 Added 45.95%
108 $113,000
Q1 2024

Apr 12, 2024

BUY
$902.69 - $993.35 $66,799 - $73,507
74 New
74 $71,000
Q1 2022

Apr 21, 2022

BUY
$595.12 - $698.43 $44,038 - $51,683
74 New
74 $52,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.